[Breaking] "Five Domestic Companies Enter COVID-19 Vaccine Clinical Trials... Aim to Start Phase 3 in Second Half" View original image

[Asia Economy Reporter Lim Juhyung] Domestic companies have officially begun clinical trials for the development of COVID-19 vaccines.


The Ministry of Health and Welfare reported the status of domestic vaccine development at the 'Special COVID-19 Response Quarantine Inspection Meeting' chaired by President Moon Jae-in on the 12th.



Currently, a total of five companies?SK Bioscience, UbioLogics, Cellid, Genexine, and GeneOne Life Science?have entered COVID-19 vaccine clinical trials, aiming to start Phase 3 clinical trials from the second half of this year.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing